Hyperlipidemia
📧 Sign up to get email alerts when something new happens for Hyperlipidemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-10-31FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for the fixed-dose combination of amlodipine besylate and atorvastatin calcium, manufactured by …
-
FDA approval · 2012-10-31FDA Approved: ZOCOR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for ZOCOR (simvastatin) submitted by Organon LLC.
-
FDA approval · 2012-10-31FDA Approved: LIVALO — Supplemental Application (Kowa Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for LIVALO (pitavastatin calcium) submitted by Kowa Pharmaceuticals America, expanding or updati…
-
CLINICAL_TRIALS trial_result · 2012-10-30Clinical Trial Update: Effect of Tenofovir Disoproxil Fumarate on Lipid Levels in HIV Infected Adults on Stable Anti-HIV Drug Therapy [NA]
A completed clinical trial evaluated the effect of tenofovir disoproxil fumarate on lipid levels in HIV-infected adults on stable antiretrov…
-
CLINICAL_TRIALS trial_result · 2012-10-29Clinical Trial Update: CCRC: Understanding the Effects of Omega-3 Fatty Acids Versus Lignans in Flaxseed on Metabolic and Inflammatory Markers Leading to Diabetes and Cardiovascular Disease [NA]
This clinical trial comparing omega-3 fatty acids versus lignans in flaxseed for metabolic and inflammatory markers related to diabetes and …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-10-19FDA Approved: FENOFIBRATE — Supplemental Application (Amneal Pharmaceuticals NY LLC)
The FDA approved Amneal Pharmaceuticals NY LLC’s supplemental application for fenofibrate, authorizing the generic product's approval.
-
FDA approval · 2012-10-12FDA Approved: LOVASTATIN — Supplemental Application (Carlsbad Technology, Inc.)
The FDA approves a supplemental application for Lovastatin from Carlsbad Technology, Inc., enabling approval of a generic lovastatin product…
-
CLINICAL_TRIALS trial_result · 2012-10-12Clinical Trial Update: Trial to Evaluate Safety and Tolerability of ALN-PCS02 in Subjects With Elevated LDL-Cholesterol (LDL-C) [Phase 1]
Phase 1 trial evaluating the safety and tolerability of ALN-PCS02 in adults with elevated LDL-cholesterol has completed.
-
CLINICAL_TRIALS trial_result · 2012-10-04Clinical Trial Update: A Human Trial to Evaluate the Efficacy and Safety of Aged Garlic Powder on Improvement of Blood Lipids in Subjects With Hyperlipidemia [Phase 2, Phase 3]
A clinical trial evaluated the efficacy and safety of aged garlic powder for improving blood lipid levels in adults with hyperlipidemia (Pha…
-
FDA approval · 2012-09-28FDA Approved: SIMVASTATIN — Supplemental Application (Accord Healthcare, Inc.)
FDA approved a supplemental application for Simvastatin from Accord Healthcare, Inc., updating the approval status under the ANDA.
-
CLINICAL_TRIALS research · 2012-09-20Clinical Trial Update: Improving Antihypertensive and Lipid-Lowering Therapy [NA]
This clinical trial update concerns improving antihypertensive and lipid-lowering therapy. No phase or status details are provided.
-
CLINICAL_TRIALS trial_result · 2012-09-17Clinical Trial Update: the Effect of a Red Rice Nutrition Supplement on Cholesterol Levels [Phase 4]
Phase 4 clinical trial assessing the effect of a red yeast rice (red rice) nutrition supplement on lipid parameters (total cholesterol, HDL,…
-
CLINICAL_TRIALS trial_result · 2012-09-07Clinical Trial Update: Safety and Efficacy Study of Herbal Supplements in Prediabetic and Mild to Moderate Hyperlipidemic Patients [NA]
A completed clinical trial evaluating the safety and efficacy of herbal supplements in adults with prediabetes and mild to moderate hyperlip…
-
FDA approval · 2012-09-05FDA Approved: FENOFIBRIC ACID — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for fenofibric acid from Amneal Pharmaceuticals of New York LLC.
-
CLINICAL_TRIALS research · 2012-09-05Clinical Trial Update: Reducing Clinical Inertia in Diabetes Care [NA]
This is a completed clinical trial update from HealthPartners Institute about reducing clinical inertia in diabetes care, with related condi…
-
CLINICAL_TRIALS trial_result · 2012-08-31Clinical Trial Update: A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Low Density Lipoprotein (LDL) Cholesterol [Phase 2]
Phase 2 pharmacodynamic study evaluating a fixed-dose combination pill's effect on lowering LDL cholesterol was terminated; results were pos…
-
CLINICAL_TRIALS trial_result · 2012-08-09Clinical Trial Update: Additive Effects of Pravastatin and Valsartan [Phase 4]
Phase 4 clinical trial evaluating the additive effects of pravastatin and valsartan in patients with hypertension and high cholesterol.
-
CLINICAL_TRIALS trial_result · 2012-08-02Clinical Trial Update: Switch to Atazanavir and Brachial Artery Reactivity (SABAR) Study [Phase 3]
A Phase 3 trial evaluating switching HIV patients to atazanavir and its effect on brachial artery reactivity in individuals with hyperlipide…
-
FDA approval · 2012-07-26FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
The FDA granted supplemental approval for a fixed-dose combination product of amlodipine and atorvastatin by Prasco Laboratories. This appro…
-
FDA approval · 2012-07-20FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (CIPLA USA INC.)
FDA approved a supplemental application for Pravastatin Sodium by Cipla USA Inc., marking an approved change to the product's approval.
-
FDA approval · 2012-07-20FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for pravastatin sodium from Dr. Reddy's Laboratories Limited.
-
FDA approval · 2012-07-17FDA Approved: ATORVASTATIN CALCIUM — Original Application (Dr. Reddy's Laboratories Limited)
FDA approves Dr. Reddy's Laboratories Limited's generic atorvastatin calcium for lipid-lowering therapy under an original ANDA.
-
FDA approval · 2012-07-17FDA Approved: ATORVASTATIN CALCIUM — Original Application (Dr. Reddy's Laboratories Limited)
FDA approved Dr. Reddy's Laboratories' atorvastatin calcium as an original ANDA, enabling a generic atorvastatin calcium product.
-
FDA approval · 2012-07-12FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Quallent)
FDA approved a supplemental application for pravastatin sodium (Quallent), resulting in an approved change to the generic product.
-
FDA approval · 2012-07-09FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for Welchol (colesevelam hydrochloride) submitted by Cosette Pharmaceuticals, Inc.